The proliferation capacity was assessed via cell counts; ICC for KI67 and nestin; CD15, CD133, and CD184 FACS; and qPCR for markers of pluripotency and proliferation. This evidence concerns the gene CXCR4 and intrahepatic cholangiocarcinoma.